DNTH
NASDAQ · Biotechnology
Dianthus Therapeutics Inc
$87.53
+0.16 (+0.18%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+109.25%
1Y
+382.52%
YTD
+120.59%
Open$86.41
Previous Close$87.37
Day High$88.97
Day Low$84.61
52W High$96.50
52W Low$16.64
Volume—
Avg Volume1.49M
Market Cap4.51B
P/E Ratio—
EPS$-4.14
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.37
Above
SMA 200
$31.95
Above
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-55.6% upside
Current
$87.53
$87.53
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.94M | 305.72M | 270.76M |
| Net Income | -234,374,855 | -32,339,215 | -26,813,974 |
| Profit Margin | -7,973.3% | -10.6% | -9.9% |
| EBITDA | -256,732,378 | -32,605,970 | -27,281,394 |
| Free Cash Flow | — | -20,890,110 | -21,520,158 |
| Rev Growth | — | +9.7% | -3.3% |
| Debt/Equity | — | 0.57 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |